ES2041681T3 - Tratamiento de infecciones fungosas. - Google Patents

Tratamiento de infecciones fungosas.

Info

Publication number
ES2041681T3
ES2041681T3 ES198787303175T ES87303175T ES2041681T3 ES 2041681 T3 ES2041681 T3 ES 2041681T3 ES 198787303175 T ES198787303175 T ES 198787303175T ES 87303175 T ES87303175 T ES 87303175T ES 2041681 T3 ES2041681 T3 ES 2041681T3
Authority
ES
Spain
Prior art keywords
treatment
fungal infections
pseudomonos
salts
acids
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES198787303175T
Other languages
English (en)
Spanish (es)
Inventor
Pamela Ann Hunter
Valerie Berry
Norman Andrew Orr
Joshua Oduro-Yeboah
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Beecham Group PLC
Original Assignee
Beecham Group PLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB868615669A external-priority patent/GB8615669D0/en
Priority claimed from GB868629641A external-priority patent/GB8629641D0/en
Application filed by Beecham Group PLC filed Critical Beecham Group PLC
Application granted granted Critical
Publication of ES2041681T3 publication Critical patent/ES2041681T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
ES198787303175T 1986-06-26 1987-04-10 Tratamiento de infecciones fungosas. Expired - Lifetime ES2041681T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB868615669A GB8615669D0 (en) 1986-06-26 1986-06-26 Treatment
GB868629641A GB8629641D0 (en) 1986-12-11 1986-12-11 Treatment

Publications (1)

Publication Number Publication Date
ES2041681T3 true ES2041681T3 (es) 1993-12-01

Family

ID=26290960

Family Applications (1)

Application Number Title Priority Date Filing Date
ES198787303175T Expired - Lifetime ES2041681T3 (es) 1986-06-26 1987-04-10 Tratamiento de infecciones fungosas.

Country Status (8)

Country Link
US (1) US4790989A (2)
EP (1) EP0251434B1 (2)
AU (1) AU600264B2 (2)
DE (1) DE3780091T2 (2)
DK (1) DK186087A (2)
ES (1) ES2041681T3 (2)
GR (1) GR3005660T3 (2)
IE (1) IE59628B1 (2)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8718886D0 (en) * 1987-08-10 1987-09-16 Ici America Inc Composition
US5279830A (en) * 1990-04-16 1994-01-18 Intellectual Property Holding Co. Mineral oil free and lanolin free cosmetic composition
US5026554A (en) * 1990-09-13 1991-06-25 Merck & Co., Inc. Method of inhibiting fungal growth using squalene synthetase inhibitors
GB9026873D0 (en) * 1990-12-11 1991-01-30 Beecham Group Plc Novel compounds
US5594026A (en) * 1990-12-11 1997-01-14 Smithkline Beecham Group P.L.C. Polymorphs of crystalline mupirocin
CN1102410C (zh) * 1993-10-22 2003-03-05 史密丝克莱恩比彻姆公司 莫匹罗星钙盐的乳膏组合物
GB9507825D0 (en) * 1995-04-18 1995-05-31 Wet Pieter M De Method of treatment
GB9616208D0 (en) 1996-08-01 1996-09-11 Smithkline Beecham Plc Novel Compounds
CO4910145A1 (es) * 1996-10-01 2000-04-24 Smithkline Beecham Corp Uso
WO1998014189A1 (en) * 1996-10-01 1998-04-09 Smithkline Beecham Corporation Use of mupirocin for the manufacture of a medicament for the treatment of bacterial infections associated with colonisation of the nasopharynx by pathogenic organisms
US6716435B1 (en) * 1997-04-18 2004-04-06 Ganeden Biotech, Inc. Absorbent product containing absorbent structure and Bacillus coagulans
US6645506B1 (en) * 1997-04-18 2003-11-11 Ganeden Biotech, Inc. Topical compositions containing extracellular products of Pseudomonas lindbergii and Emu oil
WO1999007341A1 (en) * 1997-08-09 1999-02-18 Smithkline Beecham Plc Compositions for nasal administration
WO1999012520A1 (en) * 1997-09-11 1999-03-18 Smithkline Beecham Plc Compositions adapted for prolonged residence in the nasal pharynx
IL123143A (en) * 1998-02-02 2001-08-26 Agis Ind 1983 Ltd Pharmaceutical compositions containing mupirocin
GB9808470D0 (en) 1998-04-22 1998-06-17 Smithkline Beecham Plc Novel process and apparatus
HRP20010576A2 (en) 1999-02-03 2002-08-31 Biogal Gyogyszergyar Process for the preparation of pseudomonic acid a antibiotic by microbiological method
IL137363A (en) * 2000-07-18 2005-12-18 Agis Ind 1983 Ltd Pharmaceutical compositions containing mupirocin
EP1409703A4 (en) * 2001-06-21 2004-08-18 Biogal Gyogyszergyar METABOLICALLY CONTROLLED FERMENTATION PROCESS FOR THE PRODUCTION OF PSEUDOMONIC ACID
HRP20040642A2 (en) 2001-12-28 2005-10-31 Teva Gy�gyszergy�r R�szv�nyt�rsas�g Processes for preparing crystalline and amorphous mupirocin calcium
US20040224981A1 (en) * 2003-05-01 2004-11-11 Nebojsa Janjic Antibacterial methods and compositions
US20050123576A1 (en) * 2003-12-03 2005-06-09 Ilana Lavon Mupirocin compositions for topical use, an improved process of making same and methods of using same
US7589128B2 (en) * 2004-06-01 2009-09-15 Teva Gyógyszergyár Zártkörüen Müködö Részvénytársaság Process for preparation of amorphous form of a drug
EP2444067A1 (en) 2010-10-20 2012-04-25 Laboratorios Ojer Pharma S.L. Anhydrous gel comprising mupirocin
WO2016133471A1 (en) 2015-02-20 2016-08-25 Pharmacti̇ve İlaç Sanayi̇ Ve Ti̇caret A. Ş. A topical composition comprising mupirocin and dexpanthenol
US9868669B2 (en) * 2015-09-25 2018-01-16 Mitsubishi Materials Corporation Precious metal clay regeneration solution and method for regenerating precious metal clay

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3837322A (en) * 1973-07-30 1974-09-24 Honda Motor Co Ltd Carburetor choke
CA1196284A (en) * 1982-05-28 1985-11-05 Joshua Oduro-Yeboah Pharmaceutical formulations
GB8401965D0 (en) * 1984-01-25 1984-02-29 Beecham Group Plc Composition
GB8415579D0 (en) * 1984-06-19 1984-07-25 Beecham Group Plc Compounds
GB8428952D0 (en) * 1984-11-16 1984-12-27 Beecham Group Plc Formulations

Also Published As

Publication number Publication date
DK186087A (da) 1987-12-27
IE59628B1 (en) 1994-03-09
AU7132987A (en) 1988-01-07
GR3005660T3 (2) 1993-06-07
DE3780091D1 (de) 1992-08-06
EP0251434A3 (en) 1988-02-24
DK186087D0 (da) 1987-04-10
US4790989A (en) 1988-12-13
AU600264B2 (en) 1990-08-09
DE3780091T2 (de) 1993-02-11
IE870889L (en) 1987-12-26
EP0251434B1 (en) 1992-07-01
EP0251434A2 (en) 1988-01-07

Similar Documents

Publication Publication Date Title
ATE122885T1 (de) Mittel zur behandlung von herzerkrankungen.
FI891716A7 (fi) HIV-proteaasi-inhibiittoreita, jotka ovat käyttökelpoisia AIDS'in hoidossa
DE68927835D1 (de) Ultraschallbehandlung von Tieren
DE69104777D1 (de) Orale Arzneimittelformen von biologisch aktiven Eiweisstoffen.
IT8847858A0 (it) Agenti per la profilassi e la terapia di infezioni retrovirali
DE3587741D1 (de) Behandlung von Hautkrankheiten.
FR2582513B1 (fr) Compositions pharmaceutiques contenant de l'alfuzosine
DK185785A (da) Steril injektionssproejte navnlig til dentalt brug
DK17687D0 (da) Antiseptiske midler
DE3575076D1 (de) Katheter fuer rueckinfusion von pharmazeutischen agenten.
DE58906867D1 (de) Wässrige Dispersion von 2-(2'-Hydroxyphenyl-)benzotriazolen.
DE69316203D1 (de) Elektrochemische behandlung von oberflächen
NO178094C (no) Hudpleiepreparater
FR2668365B1 (fr) Utilisation en cosmetique des n-acetylpeptides dotes d'une activite biologique.
DE19475001I2 (de) Anthelminthische Wirkstoffkombinationen.
FI875457L (fi) Skarvning av dukars aendor.
ES2038714T3 (es) Mezclas de substancias activas fungicidas.
DE3767550D1 (de) Oberflaechenbehandlung von titangegenstaenden.
FR2680372B1 (fr) Preparations aqueuses stables d'enzymes et leur utilisation.
DE3874594D1 (de) Gaenzlich waesserige formulierungen von organophosphorpestiziden.
ATE131047T1 (de) Osteogenesis-stimulierende mittel.
NO165372C (no) Anvendelse av aminoalkanfosfonsyrer og derivater derav som fungicide midler.
DE3674321D1 (de) Behandlung geschmeidiger gewebe.
ATE109150T1 (de) Mono- und diepoxid-derivate von ll-f28249- verbindungen.
FR2427098A1 (fr) Preparations a base d'acides ribonucleiques de transfert, a activite antivirale

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 251434

Country of ref document: ES